1370 related articles for article (PubMed ID: 30381356)
1. Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens.
Mamouei Z; Alqarihi A; Singh S; Xu S; Mansour MK; Ibrahim AS; Uppuluri P
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381356
[TBL] [Abstract][Full Text] [Related]
2. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375
[No Abstract] [Full Text] [Related]
3. Screening the Pathogen Box for Identification of Candida albicans Biofilm Inhibitors.
Vila T; Lopez-Ribot JL
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795383
[TBL] [Abstract][Full Text] [Related]
4. High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors.
Siles SA; Srinivasan A; Pierce CG; Lopez-Ribot JL; Ramasubramanian AK
Antimicrob Agents Chemother; 2013 Aug; 57(8):3681-7. PubMed ID: 23689719
[TBL] [Abstract][Full Text] [Related]
5. Bioluminescence imaging increases in vivo screening efficiency for antifungal activity against device-associated Candida albicans biofilms.
Vande Velde G; Kucharíková S; Van Dijck P; Himmelreich U
Int J Antimicrob Agents; 2018 Jul; 52(1):42-51. PubMed ID: 29572043
[TBL] [Abstract][Full Text] [Related]
6. Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development.
Wall G; Chaturvedi AK; Wormley FL; Wiederhold NP; Patterson HP; Patterson TF; Lopez-Ribot JL
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104269
[TBL] [Abstract][Full Text] [Related]
7. Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms.
Khan MS; Ahmad I
J Antimicrob Chemother; 2012 Mar; 67(3):618-21. PubMed ID: 22167241
[TBL] [Abstract][Full Text] [Related]
8. Activity of Allyl Isothiocyanate and Its Synergy with Fluconazole against
Raut JS; Bansode BS; Jadhav AK; Karuppayil SM
J Microbiol Biotechnol; 2017 Apr; 27(4):685-693. PubMed ID: 28138121
[TBL] [Abstract][Full Text] [Related]
9. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.
Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K
J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780
[TBL] [Abstract][Full Text] [Related]
10. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of
Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL
mBio; 2017 Dec; 8(6):. PubMed ID: 29208749
[No Abstract] [Full Text] [Related]
11. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
12. Dectin-2-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy.
Ambati S; Ellis EC; Lin J; Lin X; Lewis ZA; Meagher RB
mSphere; 2019 Oct; 4(5):. PubMed ID: 31666315
[No Abstract] [Full Text] [Related]
13. In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi.
Nakajima R; Kitamura A; Someya K; Tanaka M; Sato K
Antimicrob Agents Chemother; 1995 Jul; 39(7):1517-21. PubMed ID: 7492096
[TBL] [Abstract][Full Text] [Related]
14. Oxadiazole-Containing Macrocyclic Peptides Potentiate Azole Activity against Pathogenic
Revie NM; Robbins N; Whitesell L; Frost JR; Appavoo SD; Yudin AK; Cowen LE
mSphere; 2020 Apr; 5(2):. PubMed ID: 32269162
[TBL] [Abstract][Full Text] [Related]
15.
Tetz G; Collins M; Vikina D; Tetz V
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917977
[TBL] [Abstract][Full Text] [Related]
16. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
17. Translation Inhibition by Rocaglates Activates a Species-Specific Cell Death Program in the Emerging Fungal Pathogen Candida auris.
Iyer KR; Whitesell L; Porco JA; Henkel T; Brown LE; Robbins N; Cowen LE
mBio; 2020 Mar; 11(2):. PubMed ID: 32156828
[TBL] [Abstract][Full Text] [Related]
18.
Romera D; Aguilera-Correa JJ; Gadea I; Viñuela-Sandoval L; García-Rodríguez J; Esteban J
J Med Microbiol; 2019 Sep; 68(9):1353-1358. PubMed ID: 31271350
[No Abstract] [Full Text] [Related]
19. Hsp90 governs dispersion and drug resistance of fungal biofilms.
Robbins N; Uppuluri P; Nett J; Rajendran R; Ramage G; Lopez-Ribot JL; Andes D; Cowen LE
PLoS Pathog; 2011 Sep; 7(9):e1002257. PubMed ID: 21931556
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of Candida albicans biofilms to fluconazole by terpenoids of plant origin.
Doke SK; Raut JS; Dhawale S; Karuppayil SM
J Gen Appl Microbiol; 2014; 60(5):163-8. PubMed ID: 25420420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
